Progress in research on persistent corneal epithelial defects
10.3980/j.issn.1672-5123.2020.10.13
- VernacularTitle:持续性角膜上皮缺损的治疗进展
- Author:
Rong-Bin Liang
1
Author Information
1. Department of Ophthalmology, the First Affiliated Hospital of Nanchang University, Nanchang 330006, Jiangxi Province, ChinaCo-first authors:Rong-Bin Liang and Shi-Nan Wu
- Publication Type:Review
- Keywords:
persistent corneal epithelial defect;
cornea;
ocular disease;
limbal stem cells;
epidermal growth factor;
amniotic membrane grafting or transplant
- From:
International Eye Science
2020;20(10):1726-1729
- CountryChina
- Language:Chinese
-
Abstract:
Persistent corneal epithelial defect(PED/PCEDs)is an eye disease that fails to form corneal epithelium rapidly even after 10-14d of corneal injury. Corneal protective epithelial destruction and stromal layer damage can easily lead to eye infection, stromal ulcer, perforation, scar formation, and even blindness. At present, clinicians still face considerable challenges in treating PED patients. Standard treatments such as wearing bandaged contact lenses and using artificial tears, while newly developed drugs can promote the formation of various growth factors to re-form the cornea, and further cooperate with the corresponding surgery to provide innervation for the cornea. In order to achieve the effect of treatment. In addition, treatment should be carried out as soon as possible after the diagnosis of PED to avoid secondary complications. This article reviews the epidemiology, etiology, diagnosis, clinical manifestation, treatment and prognosis of persistent corneal epithelial defect.
- Full text:202010013.pdf
